Y-mAbs Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of YMAB for the last quarter is 19.93 M USD, and it's 14.69% lower compared to the previous quarter. The net income of Q1 24 is -6.63 M USD.